Capital expenditure · 2011–2025
Integra Lifesciences capital expenditure
$81.4M−22.0% · FY2025
Integra Lifesciences (IART) reported $81.4M in capital expenditure for fiscal 2025, −22.0% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $81.4M | −22.0% | Open → |
| FY20242024-12-31 | $104M | +56.2% | Open → |
| FY20232023-12-31 | $66.9M | +57.9% | Open → |
| FY20222022-12-31 | $42.3M | −11.8% | Open → |
| FY20212021-12-31 | $48.0M | +23.5% | Open → |
| FY20202020-12-31 | $38.9M | −44.1% | Open → |
| FY20192019-12-31 | $69.5M | −10.6% | Open → |
| FY20182018-12-31 | $77.7M | +78.7% | Open → |
| FY20172017-12-31 | $43.5M | −8.1% | Open → |
| FY20162016-12-31 | $47.3M | +41.6% | Open → |
| FY20152015-12-31 | $33.4M | −12.9% | Open → |
| FY20142014-12-31 | $38.3M | −9.4% | Open → |
| FY20132013-12-31 | $42.3M | −38.7% | Open → |
| FY20122012-12-31 | $69.0M | +79.7% | Open → |
| FY20112011-12-31 | $38.4M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +5.5%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Integra Lifesciences capital expenditure |url=https://companiesranked.com/en/company/integra-lifesciences/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Integra Lifesciences capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/integra-lifesciences/capital-expenditureBibTeX
@misc{companiesranked-en-company-integra-lifesciences-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Integra Lifesciences capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/integra-lifesciences/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000917520-26-000011 · February 26, 2026
{{cite web |title=Integra Lifesciences capital expenditure — 10-K (0000917520-26-000011) |url=https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/iart-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.